glp 1 drug history Upgrading from Overweight: The Effects of GLP-1 Drugs on the Investment Landscape GLP-1 | Summary

The quantification mode was set to Any LC (high accuracy)

Rev Endocr Metab Disord 23(3):521539 Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Mller DV, Treppendahl MB, Verma S et al (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes

Although these data show a favorable riskbenefit profile for GLP-1RA, there are differences between individual drugs with respect to their effect on cardiorenal outcomes in the separate trials

And there is another layer of safety

Among those on the highest dose, 54.6% achieved at least 10% weight loss, 36.0% achieved 15% or more, and 18.4% achieved 20% or more